In newly diagnosed AML patients, peripheral blood CD4+ T cells (mainly Th17 cells) secrete abundant TNF-α, which binds to TNFR2 on the surface of Tregs, inducing Treg expansion and enhancing their function [145]. Here, CD4 is linked to acute myeloid leukemia.